Advertisement

Topics

Endo Pharmaceuticals Solutions Inc. Company Profile

04:46 EDT 21st September 2017 | BioPortfolio


News Articles [1864 Associated News Articles listed on BioPortfolio]

Endo Pharmaceuticals to Present at Citi 2012 Global Health Care Conference

CHADDS FORD, Pa., Feb. 13, 2012 /PRNewswire/ -- Endo Pharmaceuticals Holdings (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will pr...

Endo Pharmaceuticals to remove OPANA from the market

Endo International plc continues to believe in the safety, efficacy, and favorable benefit-risk profile of OPANA® ER (oxymorphone hydrochloride extended release) when used as intended, and notes tha...

Alexza Pharmaceuticals (ALXA) and Endo International plc - (ENDP) Head to Head Comparison

Alexza Pharmaceuticals and Endo International plc - are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitabi...

Endo to Present at Bank of America Merrill Lynch 2012 Health Care Conference

CHADDS FORD, Pa., May 4, 2012 /PRNewswire/ -- Endo (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate overview at the Bank o...

Endo gives way and withdraws opioid painkiller after FDA pressure

Endo Pharmaceuticals has announced it will remove its Opana ER opioid painkiller from the US market, a month after the FDA requested because of the potential for abuse. Dublin-based Endo said that it...

Endo Pharmaceuticals to Announce Fourth Quarter and Full Year 2011 Financial Results on February 24, 2012

CHADDS FORD, Pa., Feb. 3, 2012 /PRNewswire/ -- Endo Pharmaceuticals Holdings (Nasdaq: ENDP) will announce its fourth quarter and full year 2011 financial results on February 24, 2012 and will...

Veloxis, Endo Ventures In Deal For Paladin To Commercialize Envarsus XR

WASHINGTON (dpa-AFX) - Veloxis Pharmaceuticals A/S said that its U.S. subsidiary, Veloxis Pharmaceuticals, Inc., and Endo Ventures Limited have entered into an exclusive license, supply and distri...

In surprise move, FDA asks Endo to pull opioid

Endo Pharmaceuticals' shares spiral down as the FDa takes action to remove the highly abused drug from the market. 

PubMed Articles [768 Associated PubMed Articles listed on BioPortfolio]

Effectiveness of XP-endo Finisher and XP-endo Finisher R in removing root filling remnants: a micro-CT study.

To evaluate the efficacy of filling material removal from oval-shaped canals after the use of supplementary files (XP-endo Finisher and XP-endo Finisher R) through micro-computed tomographic (micro-CT...

Effect of inorganic regenerant properties on pharmaceutical adsorption and desorption performance on polymer anion exchange resin.

This study investigated the potential effect of four frequently used inorganic regenerant properties (i.e., ionic strength, cation type, anion type, and regeneration solution volume) on the desorption...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

On the Threading of an Inherently Directional Calixarene Wheel with Oriented Ammonium Axles.

The threading of mono-stoppered alkylbenzylammonium axles 7+ and 8+ with the calix[6]-wheel 3 can occurs by both the routes of entering of the macrocycle 3 in the cone conformation: through-the-exo-ri...

Synthesis of Cis,syndiotactic-A-alt-B Copolymers from Enantiomerically Pure Endo-2-Substituted-5,6-Norbornenes.

Cis,syndiotactic A-alt-B copolymers, where A and B are two enantiomerically pure endo-2-substituted-5,6-norbornenes with "opposite" chiralities of the endo-2-substituted-5,6-norbornene skeleton, can b...

Clinical Trials [520 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

To compare the effectiveness of a 90-day Copaxone® adherence enhancement program for a sample of MS patients who are at high risk of nonadherence and receive support from Shared Solutions...

The ValenTx Endo Bypass System in Obese Subjects

The purpose of this study is to collect clinical data to support the use of the ValenTx Endo Bypass System to improve weight loss and the resolution of comorbidities in obese subjects.

Comparing Between XP Endo Finisher and Conventional Irrigation Method On Post-Operative Flare Ups In Necrotic Teeth

Comparing the postoperative flare ups and pain after adding the XP Endo Finisher to the final irrigation protocol on necrotic mandibular premolars.

Endo-cuff Assisted Vs. Standard Colonoscopy for Polyp Detection in Bowel Cancer Screening

The study evaluates whether the use of a novel endoscopic cap (the endo-cuff) at the tip of a colonoscope improves the numbers of polyps detected during bowel cancer screening colonoscopy....

Endo-Laparoscopic Approach Versus Conventional Open Surgery in Obstructing Left-Sided Colon Cancer: RCT

Objective: Whether temporary endoscopic decompression by Self-expanding metal stents (SEMS) could allow these patients to undergo successful laparoscopic resection (endo-laparoscopic appro...

Companies [2618 Associated Companies listed on BioPortfolio]

Endo Pharmaceuticals

Endo Pharmaceuticals are a specialty pharmaceutical company engaged in the research, development, sale and marketing of prescription pharmaceuticals used primarily to treat and manage pain.

Endo Pharmaceuticals Solutions Inc.

Endo Pharmaceuticals Inc.

Endo Pharmaceuticals Holdings Inc.

Endo Pharmaceuticals Holdings

More Information about "Endo Pharmaceuticals Solutions Inc." on BioPortfolio

We have published hundreds of Endo Pharmaceuticals Solutions Inc. news stories on BioPortfolio along with dozens of Endo Pharmaceuticals Solutions Inc. Clinical Trials and PubMed Articles about Endo Pharmaceuticals Solutions Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endo Pharmaceuticals Solutions Inc. Companies in our database. You can also find out about relevant Endo Pharmaceuticals Solutions Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record